5 Best Healthcare Stocks To Invest In

2. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 88

Johnson & Johnson (NYSE:JNJ) gained ground among investors due to its Covid-19 vaccine operations. On October 21, the healthcare company’s board announced a quarterly dividend of $1.06 per share. The stock has a dividend yield of 2.5%.

At the end of Q2, 88 hedge funds tracked by Insider Monkey reported having stakes in Johnson & Johnson (NYSE:JNJ), valued at over $7.05 billion. In the previous quarter, 81 hedge funds had positions in the company, highlighting a positive hedge fund sentiment. Fundsmith LLP is the leading shareholder of Johnson & Johnson (NYSE:JNJ) in Q2, with shares worth over $1.1 billion.

Johnson & Johnson (NYSE:JNJ) announced its Q3 results on October 19 and posted an EPS of $2.60, beating the estimates by $0.25.

Distillate Capital mentioned Johnson & Johnson (NYSE:JNJ) in its Q2 2021 investor letter. Here is what the firm has to say:

“The largest additions in the rebalance, Johnson & Johnson was around 50 and 40 basis points incrementally. J&J underperformed in the quarter while its normalized free cash flows held steady and so its position size was topped off to match the stable cash flows.”